Abstract:Introduction Delirium is common in hospital settings, with approximately 3% to 45% of older patients in hospitals developing delirium during their stay. Among the elderly and those with severe or advanced medical conditions, the reported percentage of patients with delirium is over 56%. The three motor subtypes of delirium are hyperactive, hypoactive, and mixed. Another way to characterize delirium is based on whether it is reversible, irreversible, or terminal. Objectives Identifying appropriate pharmacological treatment options among antipsychotics and their correlation with various precipitating and predisposing factors in the in-hospital context Methods This was a retrospective, cross-sectional, observational study that utilized a database created by the psychiatry department at the National Medical Center 20 de Noviembre, with data collected from April 2021 to April 2022. The database contains anonymized administrative and clinical data of patients who were seen in the psychiatry department for the diagnosis of any type of delirium, using the CAM scale for classification. The database includes records and data of hospitalized patients, encompassing all specialties at this medical center Results A total of 139 patients were included in the study, of which 39% were female and 61% were male, with a mean age of 67 and a median age of 68 years. It was observed that the average duration of delirium symptoms, from receiving the consultation to remission, was approximately 6 days (p <0.005) (OR 5.12-6.62), and the average length of hospital stay was approximately 20 days (OR 17.3-22.09). Among the patients, 50.39% were overweight, 63% had hypertension (HTA), 29% had chronic kidney injury, 24% had a history of delirium, and 73% had recent surgical interventions. Patients with diabetes mellitus had a 3.1 times higher risk, those with HTA had a 2.8 times higher risk, and those with kidney injury had a 3.8 times higher risk of having a positive CAM result. It was observed that haloperidol, used in 84% of the patients, showed the highest percentage reduction in CAM scores Image: Image 2: Conclusions The results of this study emphasize the importance of identifying risk factors associated with delirium and implementing effective treatment for this condition. It was observed that the average duration of delirium symptoms was approximately 6 days, which is relevant for understanding the course and management of this illness. Furthermore, it was found that the average hospital stay was 20 days, underscoring the burden that delirium can place on healthcare systems. In conclusion, this study highlights the importance of identifying risk factors and providing appropriate treatment, such as the use of haloperidol, to improve outcomes in patients with delirium. Disclosure of Interest None Declared

Association between antidepressant use and delirium in older adults: an analysis of the World Health Organization's global pharmacovigilance database

Delirium in nursing home residents: is there a role of antidepressants? A cross sectional study

Risk of drug-induced delirium in older patients- a pharmacovigilance study of FDA adverse event reporting system database

Drug-induced depressive symptoms: An update through the WHO pharmacovigilance database

Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time-series analysis of Medicare data

Global incidence and prevalence of delirium and its risk factors in medically hospitalized older patients: A systematic review and meta-analysis

Association between exposure to proton pump inhibitors and delirium: a descriptive and disproportionality analysis of VigiBase

Adherence to Antidepressants and Mortality in Elderly Patients with Cardiovascular Disease

P8: Risk of Delirium According to Demintia and the Use of Psychotropics

Antidepressant use in relation to dementia risk, cognitive decline, and brain atrophy

Antidepressant use and cognitive decline in community-dwelling elderly people - The Three-City Cohort

Emergency department admissions induced by drug–drug interactions in the elderly: A cross‐sectional study

Concurrent Benzodiazepine Use In Older Adults Treated With Antidepressants In Asia

Preventing and treating delirium in clinical settings for older adults

Delirium and risk of incident cardiovascular events in elderly: data from a global health research network

Association between tricyclic antidepressants and health outcomes among older people: A systematic review and meta-analysis

Trends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study

Association between first-line antidepressant use and risk of dementia in older adults: a retrospective cohort study

Trends in Delirium and New Antipsychotic and Benzodiazepine Use Among Hospitalized Older Adults Before and After the Onset of the COVID-19 Pandemic

Analysis on clinical data of elderly in-patients with delirium during psychiatric consultation at Chinese general hospitals

Socio-demographic characteristics and pharmacological treatment options in patients with delirium